MAPT and Alzheimer disease: Given frailty severity increases and accelerates 4–9 years prior to dementia [8], temporal relationships that should be explored include the changes in frailty in relation to amyloid, tau, neuroinflammation, neurodegeneration and synaptic dysfunction biomarkers in preclinical AD to progression to MCI/dementia.